Quinn Opportunity Partners LLC Bio N Tech Se Call Options Transaction History
Quinn Opportunity Partners LLC
- $874 Million
- Q1 2024
Call Options
1 transactions
Others Institutions Holding BNTX
# of Institutions
326Shares Held
40.4MCall Options Held
1.31MPut Options Held
1.37M-
Baillie Gifford & CO8.36MShares$672 Million0.61% of portfolio
-
Primecap Management CO Pasadena, CA4.81MShares$386 Million0.34% of portfolio
-
Harding Loevner LP Bridgewater, NJ3.82MShares$307 Million2.24% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M3.47MShares$279 Million1.4% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U03.43MShares$276 Million1.76% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $19.5B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...